Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
NCT00882895Phase 2Active, not recruiting
- Sponsor
- Washington University School of Medicine
- Start
- May 2009
- Primary completion
- Jun 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in non-Hodgkin lymphoma (NHL), sponsored by Washington University School of Medicine. Started May 2009; status: active, not recruiting.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00882895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00882895.